Status:
COMPLETED
The Effect of Ketamine on Postoperative Cognitive Dysfunction.
Lead Sponsor:
Assiut University
Conditions:
Postoperative Cognitive Dysfunction
Eligibility:
All Genders
60+ years
Phase:
PHASE4
Brief Summary
Available evidence suggests that there is no significant difference in the incidence of postoperative cognitive dysfunction POCD when general anaesthesia and regional anaesthesia are compared\[13, 14\...
Eligibility Criteria
Inclusion
- patients scheduled for orthopaedic surgery under spinal anaesthesia.
- ASA physical status I to II.
Exclusion
- Patients with a history of psychosis, schizophrenia, nephropathy, uncontrolled blood pressure, uncontrolled hepatic disorders, or allergy to ketamine.
- Patients With moderate to severe depression according to Yesavage abbreviated Geriatric Depression Scale,
- Patients presented with postoperative delirium or required medications other than study drugs.
- Ketamine administration is contraindicated.
Key Trial Info
Start Date :
December 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 9 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04321746
Start Date
December 10 2020
End Date
March 9 2022
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University hospital
Asyut, Asyut Governorate, Egypt, 11111